Emcure Pharma News

Emcure Pharma reported a 36% jump in Q1 profit and a 23% rise in revenue, while also announcing the appointment of Samit Mehta as its new COO.

Emcure Pharmaceuticals reported a 36.2% increase in net profit and a 23% rise in revenue for the first quarter, alongside a 25.8% growth in EBITDA. The company

ब्रोकरेज फर्मों ने Emcure Pharma और Fineotex Chemical सहित 7 शेयरों पर बुलिश रेटिंग दी है, जिसमें 84% तक की तेजी की उम्मीद है।

Emcure Pharmaceuticals has received CDSCO approval to market its brand Poviztra for the treatment of fatty liver (metabolic dysfunction-associated steatohepatit

Emcure Pharma is acquiring the remaining 12.05% stake in Gennova Biopharmaceuticals, taking full control to simplify ownership and sharpen strategic focus. Sami